Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2007

01.06.2007

The Pylorus: Take It or Leave It? Systematic Review and Meta-Analysis of Pylorus-Preserving versus Standard Whipple Pancreaticoduodenectomy for Pancreatic or Periampullary Cancer

verfasst von: Paul J. Karanicolas, MD, Edward Davies, MD, Regina Kunz, MD, MSc, Matthias Briel, MD, H. Pavan Koka, MD, Darrin M. Payne, MD, Shona E. Smith, MD, Hui-Ping Hsu, MD, Pin-Wen Lin, MD, Christian Bloechle, MD, Karl-Joseph Paquet, MD, Gordon H. Guyatt, MD, MSc

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Our objective was to determine the relative effects of pylorus-preserving pancreaticoduodenectomy (PPPD) and standard Whipple pancreaticoduodenectomy (SWPD) in patients with pancreatic or periampullary cancer.

Methods

We searched seven bibliographic databases, conference proceedings, and reference lists of articles and textbooks, and we contacted experts in the field of hepatobiliary surgery. We included published and unpublished randomized controlled trials. We evaluated the methodological quality of trials and, in duplicate, extracted data regarding operative, perioperative, and long-term outcomes. We contacted all authors and asked them to provide additional information regarding the trials. We pooled results from the studies by using a random-effects model, evaluated the degree of heterogeneity, and explored potential explanations for heterogeneity.

Results

Six trials that included a total of 574 patients met eligibility criteria. In the pooled analysis, PPPD was 72 minutes faster (P < .001, 95% confidence interval [95% CI], 53–92), with 284 mL less blood loss (P < .001, 95% CI, 176–391) and .66 fewer units of blood transfused (P = .002, 95% CI, .25–1.16). Other perioperative and long-term outcomes did not statistically differ, although the confidence intervals include important differences.

Conclusions

Moderate-quality evidence suggests PPPD is a faster procedure with less blood loss compared with SWPD. Large absolute differences in other key outcomes are unlikely; excluding relatively small differences will, however, require larger, methodologically stronger trials.
Literatur
1.
Zurück zum Zitat Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics. CA Cancer J Clin 2003; 53:5–26PubMedCrossRef Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics. CA Cancer J Clin 2003; 53:5–26PubMedCrossRef
2.
Zurück zum Zitat Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg 1999; 189:1–7PubMedCrossRef Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg 1999; 189:1–7PubMedCrossRef
3.
Zurück zum Zitat Hedberg M, Borgstrom A, Genell S, Janzon L. Survival following panceatic carcinoma: a follow-up study of all cases recorded in Malmo, Sweden, 1977–1991. Br J Surg 1998; 85:1641–4PubMedCrossRef Hedberg M, Borgstrom A, Genell S, Janzon L. Survival following panceatic carcinoma: a follow-up study of all cases recorded in Malmo, Sweden, 1977–1991. Br J Surg 1998; 85:1641–4PubMedCrossRef
4.
Zurück zum Zitat Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic cancer and incidence of the disease in the West Midlands. An epidemiological study. Br J Surg 1995; 82:111–5PubMedCrossRef Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic cancer and incidence of the disease in the West Midlands. An epidemiological study. Br J Surg 1995; 82:111–5PubMedCrossRef
5.
Zurück zum Zitat Kausch W. Das Carcinom der Papilla duodeni und seine radikale Entfernung. Bruns Beitr Klin Chir 1912; 78:439–86 Kausch W. Das Carcinom der Papilla duodeni und seine radikale Entfernung. Bruns Beitr Klin Chir 1912; 78:439–86
6.
Zurück zum Zitat Whipple AO, al. e. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935; 102:763–79 Whipple AO, al. e. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935; 102:763–79
7.
Zurück zum Zitat Watson K. Carcinoma of the ampulla of Vater. Successful radical resection. Br J Surg 1944; 31:368–73CrossRef Watson K. Carcinoma of the ampulla of Vater. Successful radical resection. Br J Surg 1944; 31:368–73CrossRef
8.
Zurück zum Zitat Traverso LW, Longmire WPJ. Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978; 146:959–62PubMed Traverso LW, Longmire WPJ. Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978; 146:959–62PubMed
9.
Zurück zum Zitat Carter D, Russell R, Pitt H (eds). Rob and Smith’s Operative Surgery: Hepatobiliary and Pancreatic Surgery. 5th ed. London: Chapman & Hall, 1996 Carter D, Russell R, Pitt H (eds). Rob and Smith’s Operative Surgery: Hepatobiliary and Pancreatic Surgery. 5th ed. London: Chapman & Hall, 1996
10.
Zurück zum Zitat Howard J, Idezuki Y, Ihse I, Prinz R (eds). Surgical Diseases of the Pancreas. 3rd ed. Baltimore: Williams & Wilkins, 1998 Howard J, Idezuki Y, Ihse I, Prinz R (eds). Surgical Diseases of the Pancreas. 3rd ed. Baltimore: Williams & Wilkins, 1998
11.
Zurück zum Zitat Donner A, Klar N. The statistical analysis of kappa statistics in multiple samples. J Clin Epidemiol 1996; 49:1053–8PubMedCrossRef Donner A, Klar N. The statistical analysis of kappa statistics in multiple samples. J Clin Epidemiol 1996; 49:1053–8PubMedCrossRef
12.
Zurück zum Zitat Fleiss J. The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2:121–45PubMed Fleiss J. The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2:121–45PubMed
13.
Zurück zum Zitat Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001; 323:42–6PubMedCrossRef Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001; 323:42–6PubMedCrossRef
14.
Zurück zum Zitat Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282:1054–60PubMedCrossRef Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282:1054–60PubMedCrossRef
15.
Zurück zum Zitat Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Method 2005; 5:13CrossRef Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Method 2005; 5:13CrossRef
16.
Zurück zum Zitat Dickerson K, Chan S, Chalmers T, Sacks H, Smith HJ. Publication bias and clinical trials. Control Clin Trials 1987; 8:343–53CrossRef Dickerson K, Chan S, Chalmers T, Sacks H, Smith HJ. Publication bias and clinical trials. Control Clin Trials 1987; 8:343–53CrossRef
17.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177–88PubMedCrossRef DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177–88PubMedCrossRef
18.
Zurück zum Zitat Breslow N, Day N. Combination of results from a series of 2 × 2 tables; control of confounding. In: Statistical Methods in Cancer Research, vol. 1, The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer, 1980:136–46 Breslow N, Day N. Combination of results from a series of 2 × 2 tables; control of confounding. In: Statistical Methods in Cancer Research, vol. 1, The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer, 1980:136–46
19.
Zurück zum Zitat Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539–58PubMedCrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539–58PubMedCrossRef
20.
Zurück zum Zitat Sackett D, Haynes R, Guyatt G, Tugwell P. Clinincal Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston: Little, Brown, 1991:30 Sackett D, Haynes R, Guyatt G, Tugwell P. Clinincal Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston: Little, Brown, 1991:30
21.
Zurück zum Zitat Guyatt G, Sinclair J, Cook D, Glasziou P. Users’ guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group. JAMA 1999; 281:1836–43PubMedCrossRef Guyatt G, Sinclair J, Cook D, Glasziou P. Users’ guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group. JAMA 1999; 281:1836–43PubMedCrossRef
22.
Zurück zum Zitat Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490–4PubMedCrossRef Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490–4PubMedCrossRef
23.
Zurück zum Zitat Guyatt GH, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines. Chest 2006; 129:174–81PubMedCrossRef Guyatt GH, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines. Chest 2006; 129:174–81PubMedCrossRef
24.
Zurück zum Zitat Bell RH Jr. Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes. Cancer Treat Rev 2005; 31:328–31PubMedCrossRef Bell RH Jr. Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes. Cancer Treat Rev 2005; 31:328–31PubMedCrossRef
25.
Zurück zum Zitat Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999; 86:603–7PubMedCrossRef Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999; 86:603–7PubMedCrossRef
26.
Zurück zum Zitat Lin PW, Shan YS, Lin YJ, Hung CJ. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 2005; 52:1601–4PubMed Lin PW, Shan YS, Lin YJ, Hung CJ. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 2005; 52:1601–4PubMed
27.
Zurück zum Zitat Tran KT, Smeenk HG, van Eijck CH, et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 2004; 240:738–45PubMedCrossRef Tran KT, Smeenk HG, van Eijck CH, et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 2004; 240:738–45PubMedCrossRef
28.
Zurück zum Zitat Wenger FA, Jacobi CA, Haubold K, Zieren HU, Muller JM. Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy. Chirurg 1999; 70:1454–9PubMedCrossRef Wenger FA, Jacobi CA, Haubold K, Zieren HU, Muller JM. Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy. Chirurg 1999; 70:1454–9PubMedCrossRef
29.
Zurück zum Zitat Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005; 92:547–56PubMedCrossRef Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005; 92:547–56PubMedCrossRef
30.
Zurück zum Zitat Seiler CA, Wagner M, Schaller B, Sadowski C, Kulli C, Buchler MW. Pylorus preserving or classical Whipple operation in tumors. Initial clinical results of a prospective randomized study. Swiss Surg 2000; 6:275–82PubMedCrossRef Seiler CA, Wagner M, Schaller B, Sadowski C, Kulli C, Buchler MW. Pylorus preserving or classical Whipple operation in tumors. Initial clinical results of a prospective randomized study. Swiss Surg 2000; 6:275–82PubMedCrossRef
31.
Zurück zum Zitat Seiler CA, Wagner M, Sadowski C, Kulli C, Buchler MW. Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 2000; 4:443–52PubMedCrossRef Seiler CA, Wagner M, Sadowski C, Kulli C, Buchler MW. Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 2000; 4:443–52PubMedCrossRef
32.
Zurück zum Zitat Paquet K-J. Comparison of Whipple’s pancreaticoduodenectomy with the pylorus- preserving pancreaticoduodenectomy—a prospectively controlled, randomized long-term trial. Chir Gastroenterol 1998; 14:54–8CrossRef Paquet K-J. Comparison of Whipple’s pancreaticoduodenectomy with the pylorus- preserving pancreaticoduodenectomy—a prospectively controlled, randomized long-term trial. Chir Gastroenterol 1998; 14:54–8CrossRef
33.
Zurück zum Zitat Bloechle C, Broering DC, Latuske C, Latuske M, v Schrenck T, Izbicki JR. Prospective randomized study to evaluate quality of life after partial pancreatoduodenectomy according to whipple versus pylorus preserving pancreatoduodenectomy according to longmire-traverso for periampullary carcinoma. Deutsche Gesellschaft Chir 1999; (Suppl 1):661–4 Bloechle C, Broering DC, Latuske C, Latuske M, v Schrenck T, Izbicki JR. Prospective randomized study to evaluate quality of life after partial pancreatoduodenectomy according to whipple versus pylorus preserving pancreatoduodenectomy according to longmire-traverso for periampullary carcinoma. Deutsche Gesellschaft Chir 1999; (Suppl 1):661–4
34.
Zurück zum Zitat Sharp KW, Ross CB, Halter SA, Morrison JG, Richards WO. Pancreaticoduodenectomy with pyloric preservation for carcinoma of the pancreas: a cautionary note. Surgery 1988; 105:645–53 Sharp KW, Ross CB, Halter SA, Morrison JG, Richards WO. Pancreaticoduodenectomy with pyloric preservation for carcinoma of the pancreas: a cautionary note. Surgery 1988; 105:645–53
35.
Zurück zum Zitat Moosa AR. Pancreatic cancer. Approach to diagnosis, selection for surgery and choice of operation. Cancer 1982; 50:2689–98 Moosa AR. Pancreatic cancer. Approach to diagnosis, selection for surgery and choice of operation. Cancer 1982; 50:2689–98
36.
Zurück zum Zitat Devereaux PJ, Bhandari M, Clarke M, et al. Need for expertise based randomised controlled trials. BMJ 2005; 330:88PubMedCrossRef Devereaux PJ, Bhandari M, Clarke M, et al. Need for expertise based randomised controlled trials. BMJ 2005; 330:88PubMedCrossRef
Metadaten
Titel
The Pylorus: Take It or Leave It? Systematic Review and Meta-Analysis of Pylorus-Preserving versus Standard Whipple Pancreaticoduodenectomy for Pancreatic or Periampullary Cancer
verfasst von
Paul J. Karanicolas, MD
Edward Davies, MD
Regina Kunz, MD, MSc
Matthias Briel, MD
H. Pavan Koka, MD
Darrin M. Payne, MD
Shona E. Smith, MD
Hui-Ping Hsu, MD
Pin-Wen Lin, MD
Christian Bloechle, MD
Karl-Joseph Paquet, MD
Gordon H. Guyatt, MD, MSc
Publikationsdatum
01.06.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9330-3

Weitere Artikel der Ausgabe 6/2007

Annals of Surgical Oncology 6/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.